IBUPROFEN ALONE & IN COMBINATION WITH ACETAMINOPHEN FOR FEVER

单独布洛芬

• 批准号: 7951254
• 负责人: IAN A. PAUL
• 金额: $ 1.02万
• 依托单位: PENNSYLVANIA STATE UNIV HERSHEY MED CTR
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951254
• 关键词: Acetaminophen; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Dose; Fever; Funding; Grant; Hour; Ibuprofen; Institution; Research; Research Personnel; Resources; Schedule; Source; Treatment Protocols; United States National Institutes of Health

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The investigators hypothesize that combination and alternating regimens of acetaminophen and ibuprofen will be superior to ibuprofen alone for antipyresis in a single six-hour dosing schedule.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 研究人员假设对对乙酰氨基酚和布洛芬的结合和交替方案将在单个六小时的剂量时间表中仅优于布洛芬。